2018 American Transplant Congress » Concurrent Session: Novel Therapeutics
Date: Sunday, June 3, 2018
Time: 4:30pm-6:00pm
Location: Room 602/603/604
Session Type: Concurrent Session
Meeting: 2018 American Transplant Congress
- 4:30pm-4:42pm
Anti-TIRC7 Antibody Acts Synergistically with Tacrolimus in Promoting Graft Survival in a Rat Kidney Transplant Model
- 4:42pm-4:54pm
Combination Proteasome Inhibition and Anti-BAFF Therapy Permits Highly Sensitized Rhesus Kidney Transplantation
- 5:06pm-5:18pm
Prolonged Graft Survival in Old Recipients is Abrogated by Immunosuppressive Treatment with CTLA4-Ig
- 5:18pm-5:30pm
Metabolic Therapy as a Platform for CTLA4Ig Costimulation Blockade in Preventing Allograft Rejection
« View all sessions from the 2018 American Transplant Congress